Search
Generic filters
Search in excerpt
Search
Generic filters
Search in excerpt
Back to All Products

PSYK

Horizons Psychedelic Stock Index ETF

The World’s First Psychedelics ETF

Within the last decade, there has been a significant re-evaluation of the potential therapeutic benefits of psychedelics, and a movement to research these substances and potentially use them for therapeutic use, particularly in the treatment of mental health issues. Horizons Psychedelic Stock Index ETF (PSYK) is the world’s first psychedelics-focused ETF providing investors a new way to get exposure to this emerging healthcare sector.

North American Psychedelics Index

Constituents are listed on North American exchanges and are publicly listed life sciences companies focused on psychedelic medicine, and other companies with business activities in the psychedelics industry. While securities may be listed on the TSX, NYSE or Nasdaq Global Market, many of these securities may trade on North American junior exchanges that include (but are not limited to) the:
• TSX Venture Exchange
• Canadian Securities Exchange
• NEO Exchange
• NASDAQ Stock Market
• NYSE American

Investment Objective

PSYK seeks to replicate, to the extent possible and net of expenses, the performance of a market index that is designed to provide exposure to the performance of a basket of North American publicly-listed life sciences companies having significant business activities in, or significant exposure to, the psychedelics industry. Currently, the ETF seeks to replicate the performance of the North American Psychedelics Index, net of expenses.

Fund Details

Ticker
PSYK
Inception Date
January 26, 2021
Net Assets ?
$25,153,083
As at August 12, 2022
Consolidated Prior Day Volume ?
1,343
For August 12, 2022
Average Daily Trading Volume Over a 12 Month Period ?
25,424
As at August 12, 2022
Exchange
NEO Exchange
Investment Manager
Horizons ETFs Management (Canada) Inc.
Eligibility
All Registered and Non-Registered Investment Accounts
Bloomberg Index Ticker
HPSYKTR
Management Fee
0.85%
(Plus applicable sales tax)
Management Expense Ratio ?
0.99%
As at December 31, 2021
Currency
CAD
Currency Hedging
N/A
LEI ?
5493003DII1O2LYBVQ81
Most Recent Distributions Per Unit
0.03023
Estimated Annualized Yield ?
0.42%
12-Month Trailing Yield ?
1.04%
Distribution Frequency
Record Date
September 29, 2021
NAV / Unit
$13.0941
Price
$13.09
Premium Discount
$0.00
Premium Discount Percentage
-0.03%
Outstanding Shares
1,920,954

The NAV chart above only shows the historical daily net asset value per unit (NAV) of the ETF, and identifies the various distributions made by the ETF, if any. The distributions are not treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses. The chart is not a performance chart and is not indicative of future NAV values which will vary.

The Growth of 10K chart above is based on the historical daily net asset value per unit (NAV) of the ETF, and represents the value of an initial investment into the ETF of $10,000 since its inception, on a total return basis. Distributions, if any, are treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses where paid by the fund. The chart is not a performance chart and is not indicative of future value which will vary.

Annualized Performance (%) *

1mo 3mo 6mo YTD 1 yr 3 yr 5 yr 10 yr SIR**
Horizons Psychedelic Stock Index ETF 9.93 0.74 -26.88 -38.05 -66.30 -- -- -- -53.76
North American Psychedelics Index 10.16 1.74 -25.56 -37.88 -65.65 -- -- -- -53.66

**Fund performance since inception on January 26, 2021, as at July 31, 2022

Calendar Year Performance (%) *

Calendar year performance data is not currently available.

Distributions

Year Ex-Dividend Date Record Date Payment Date Payment Amount Reinvested Non-Cash Distributions Distribution Period
2021 09/28/2021 09/29/2021 10/13/2021 0.03023

Top 10 Holdings

As at August 05, 2022
Security Name Weight
COMPASS PATHWAYS PLC ADR 18.26%
SEELOS THERAPEUTICS INC . 13.02%
GH RESEARCH PLC . 12.51%
ATAI LIFE SCIENCES NV . 10.00%
Revive Therapeutics Ltd 8.87%
CYBIN INC . 8.19%
Numinus Wellness Inc 7.09%
Field Trip Health Ltd 6.48%
MIND MEDICINE MINDMED INC 5.14%
Johnson & Johnson 4.11%

Holdings are subject to change. Download full prior business day: Holdings

At a Glance

The World’s First Psychedelics ETF

Within the last decade, there has been a significant re-evaluation of the potential therapeutic benefits of psychedelics, and a movement to research these substances and potentially use them for therapeutic use, particularly in the treatment of mental health issues. Horizons Psychedelic Stock Index ETF (PSYK) is the world’s first psychedelics-focused ETF providing investors a new way to get exposure to this emerging healthcare sector.

North American Psychedelics Index

Constituents are listed on North American exchanges and are publicly listed life sciences companies focused on psychedelic medicine, and other companies with business activities in the psychedelics industry. While securities may be listed on the TSX, NYSE or Nasdaq Global Market, many of these securities may trade on North American junior exchanges that include (but are not limited to) the:
• TSX Venture Exchange
• Canadian Securities Exchange
• NEO Exchange
• NASDAQ Stock Market
• NYSE American

Product Facts

Investment Objective

PSYK seeks to replicate, to the extent possible and net of expenses, the performance of a market index that is designed to provide exposure to the performance of a basket of North American publicly-listed life sciences companies having significant business activities in, or significant exposure to, the psychedelics industry. Currently, the ETF seeks to replicate the performance of the North American Psychedelics Index, net of expenses.

Fund Details

Ticker
PSYK
Inception Date
January 26, 2021
Net Assets ?
$25,153,083
As at August 12, 2022
Consolidated Prior Day Volume ?
1,343
For August 12, 2022
Average Daily Trading Volume Over a 12 Month Period ?
25,424
As at August 12, 2022
Exchange
NEO Exchange
Investment Manager
Horizons ETFs Management (Canada) Inc.
Eligibility
All Registered and Non-Registered Investment Accounts
Bloomberg Index Ticker
HPSYKTR
Management Fee
0.85%
(Plus applicable sales tax)
Management Expense Ratio ?
0.99%
 As at December 31, 2021
Currency
CAD
Currency Hedging
N/A
LEI ?
5493003DII1O2LYBVQ81
Most Recent Distributions Per Unit
0.03023
Estimated Annualized Yield ?
0.42%
12-Month Trailing Yield ?
1.04%
Distribution Frequency
Record Date
September 29, 2021
NAV / Unit
$13.0941
Price
$13.09
Premium Discount
$0.00
Premium Discount Percentage
-0.03%
Outstanding Shares
1,920,954

The NAV chart above only shows the historical daily net asset value per unit (NAV) of the ETF, and identifies the various distributions made by the ETF, if any. The distributions are not treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses. The chart is not a performance chart and is not indicative of future NAV values which will vary.

The Growth of 10K chart above is based on the historical daily net asset value per unit (NAV) of the ETF, and represents the value of an initial investment into the ETF of $10,000 since its inception, on a total return basis. Distributions, if any, are treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses where paid by the fund. The chart is not a performance chart and is not indicative of future value which will vary.

Performance & Distributions

Annualized Performance (%) *

1mo 3mo 6mo YTD 1 yr 3 yr 5 yr 10 yr SIR**
Horizons Psychedelic Stock Index ETF 9.93 0.74 -26.88 -38.05 -66.30 -- -- -- -53.76
North American Psychedelics Index 10.16 1.74 -25.56 -37.88 -65.65 -- -- -- -53.66

**Fund performance since inception on January 26, 2021, as at July 31, 2022

Calendar Year Performance (%)

Calendar year performance data is not currently available.

Distributions

Year Ex-Dividend Date Record Date Payment Date Payment Amount Reinvested Non-Cash Distributions Distribution Period
2021 09/28/2021 09/29/2021 10/13/2021 0.03023
Holdings

Top 10 Holdings

As at August 05, 2022
Security Name Weight
COMPASS PATHWAYS PLC ADR 18.26%
SEELOS THERAPEUTICS INC . 13.02%
GH RESEARCH PLC . 12.51%
ATAI LIFE SCIENCES NV . 10.00%
Revive Therapeutics Ltd 8.87%
CYBIN INC . 8.19%
Numinus Wellness Inc 7.09%
Field Trip Health Ltd 6.48%
MIND MEDICINE MINDMED INC 5.14%
Johnson & Johnson 4.11%

Holdings are subject to change. Download full prior business day: Holdings

Related Posts

At Horizons ETFs, we believe in education as empowerment. We endeavor to equip Canadian investors with the knowledge and tools they need to navigate the investing world. From the ETF basics to more complex topics like how our suite of inverse and leveraged funds work, our comprehensive learning library aims to be accessible for all investors, from beginners to experienced traders!